Mabcure Inc USD0.001
Mabcure, Inc., (Mabcure) is a development-stage company. The Company is engaged in the business of developing and commercializing its antibody technology for the early detection of cancer and for the creation of therapeutics against cancer. The Company originally was in the business of developing a detergent for removing pesticides from fruits and vegetables. During the year ended December 31, 2011, the Company has not generated any revenue.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.